AUROPHARMA logo

Aurobindo Pharma LTD

F&O
AUROPHARMA·NSE·
1,678.60 -38.40 (-2.24%)
Market Cap97767.42 Cr
PE Ratio27.82
Volume5,80,848
Day High - Low1700.10 - 1671.10
52W High-Low1717.00 - 1016.20
DocStoX Score
4.8/10
Weak
Fair Value
Sign in to see
ROE
10.10%
Average
P/E
27.82x
Fair
Debt / Equity
0.19
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day1671
1700
52W1016
1717
DocStoX take

Supported by risk (9.2) and momentum (7.5), but held back by growth (1.3). Risk looks strong at 9.2, but that is offset by growth at 1.3 and valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.8
/10
Weak
Quality
Solid
ROE 10.1%
Valuation
Expensive
P/E 27.8×
Growth
Flat
Revenue +6.3% 5Y CAGR
Risk
Low risk
D/E 0.19
Momentum
Strong
95% of 52-week range

At a glance

Market Cap
₹97,767 Cr
52W High / Low
₹1717 / ₹1016
Dividend Yield
0.24%
Promoter Holding
51.88%
EPS (TTM)
₹60.34
Book Value
₹652.00

Key highlights

  • Low leverage — D/E 0.19
  • Profitable in all of the last 5 years
  • Profit shrinking 8% a year
  • Growth is weak (1.3/10)
2 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

AUROBINDO PHARMA LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.